Advertisement

European Journal of Clinical Pharmacology

, Volume 8, Issue 1, pp 75–78 | Cite as

Interaction of diphenylhydantoin (DPH) and tolbutamide in man

  • H. Wesseling
  • I. Mols-Thürkow
Originals

Summary

The influence of tolbutamide administration on the plasma concentrations of diphenylhydantoin (DPH) was investigated in seventeen long-stay patients with epilepsy. Tolbutamide, 0.5 g 2-3x daily, considerably increased the proportion of non-protein-bound DPH in plasma (mean: 44.6% of control values). The increase was transient, unlike the decrease found in total plasma DPH-concentration (approx. 10% of control values).In vitro experiments confirmed that the interaction between DPH and tolbutamide was due to displacement of DPH from plasma proteins. Some factors that limit the capacity to metabolise DPH in the liver are discussed; they may increase the risk of DPH-intoxication in patients who take sulphonylureas.

Key words

Diphenylhydantoin (DPH) tolbutamide drug interaction protein-displacement 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arnold, K., Gerber, N.: The rate of decline of diphenylhydantoin in human plasma. Clin. Pharmacol. Ther.11 121–139 (1970)Google Scholar
  2. Bogoch, S., Dreyfus, J.: The broad range of use of diphenylhydantoin. Bibliography and review. New York: The Dreyfus Medical Foundation 1970Google Scholar
  3. Borondy, P., Chang, T., Glazko, A.J.: Inhibition of diphenylhydantoin hydroxylation by 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH). Fed. Proc.31 582 (1972)Google Scholar
  4. Christensen, L.K., Skovsted, L.: Inhibition of drug metabolism by chloramphenicol. Lancet1969, 1397–1399Google Scholar
  5. Cucinell, S.A., Conney, A.H., Sansur, M., Burns, J.J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clin. Pharmacol. Ther.6 420–429 (1965)Google Scholar
  6. Leubner, H., Saito, S.: Der Serumtolbutamidspiegel während der oralen Diabetesbehandlung. Wien. Klin. Wschr.82 321–324 (1970)Google Scholar
  7. Mølholm Hansen, J., Kristensen, M., Skovsted, L., Christensen, L.K.: Dicoumarol induced diphenylhydantoin intoxication, Lancet1966, 265–266Google Scholar
  8. Pannekoek, J.H.: Personal communication (1969)Google Scholar
  9. Thürkow, I., Wesseling, H., Meyer, D.K.F.: Estimation of phenytoin in body fluids in the presence of sulphonylurea compounds. Clin. chim. Acta37 509–513 (1972)Google Scholar
  10. Wesseling, H., Thürkow, I., Mulder, G.J.: Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat. Biochem. Pharmacol.22 3033–3040 (1973)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • H. Wesseling
    • 1
  • I. Mols-Thürkow
    • 1
  1. 1.Department of Clinical PharmacologyState UniversityGroningenThe Netherlands

Personalised recommendations